1 week ago MediPharm Labs’ Board Continues Value Destruction for Shareholders with Sale of Hope Facility

Complete Incompetence at the Board Level Results in Fire Sale of Treasured MediPharm Asset, the Hope Facility, to a Competitor Hope Facility was One of Canada’s Best Cultivation Assets Before it was Acquired by MediPharm, Grossly Mismanaged, and Ultimately Shut Down in 2024 MediPharm Labs’ Board is Pursuing its Worst Deal Yet: A Highly Dilutive […]

Other

3 w. ago MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan

TORONTO, May 28, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (“MediPharm” or the “Company“), a pharmaceutical company specialized in precision-based cannabinoids, today issued a Letter to Shareholders from the Company’s Board of Directors (the “Letter”). The Letter is a response to the amended and restated dissident proxy circular filed by Apollo on May […]

Other

3 w. ago iolite Partners Ltd. Issues Letter to Fellow Shareholders Urging them to WITHHOLD their votes in the election of Mr. Pierre Lépine (Chairman) at Dynacor’s Annual General Meeting

FREIENBACH, Switzerland — iolite Capital Management AG, a Switzerland-based investment manager, which beneficially owns, controls or directs approximately 10% of the issued and outstanding common shares of Dynacor Group Inc. (TSX:DNG), issued an open letter to fellow shareholders of Dynacor, urging them to WITHHOLD their votes in the election of Mr. Pierre Lépine, Chairman, at […]

Politics

3 w. ago Sherritt Issues Letter to Shareholders Highlighting Imminent Threat From a Reckless and Self

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Warning: SC2 Inc. aims to control Sherritt for its own gain, without offering a credible plan or a premium, risking the Corporation’s financial wellbeing and strategic progress Leading independent proxy advisor Glass Lewis recommends shareholders vote FOR all resolutions(1) Sherritt’s […]

Other

4 w. ago Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting

MediPharm Labs Board Continues to Obstruct the Appointment and Oversight of an Independent Chair Failure to Appoint an Independent Chair to Oversee the Election of Directors at the Annual Meeting Prevents Shareholders from Exercising their Legal Right to Hold the Current Board Accountable for their Epic Failures Board Made No Attempt to Engage with Apollo […]

Economics

4 w. ago Apollo Capital Issues a With Prejudice Offer to MediPharm Labs and Its Board of Directors to Ensure Shareholder Rights Are Protected at the 2025 Annual Meeting

Believes the Board Continues to Take Oppressive Actions Which Fundamentally Disregard the Rights and Interests of Shareholders Asserts the Board’s Unlawful, Desperate and Self-Serving Tactics Clearly Indicate That the Current Directors Will Go to Any Lengths Necessary to Entrench Themselves Requests that MediPharm Agree to Conduct the June 16th Annual Meeting Under the Oversight of an […]

Economics